| |
Press Release
Fairfield, California. August 30,
2006.
New Study Demonstrates Weight
Loss and Health Benefits of CardioTrim™
A new human clinical study has shown that Cissus
quadrangularis, a key ingredient in Soy Labs’ CardioTrim™
product line, produces significant weight loss, lowers blood sugar
and reduces total and LDL (bad) cholesterol. Results of the
double-blind, placebo-controlled study were presented at the First
World Congress on Therapies Against Obesity earlier this year in
Paris. The study was presented by lead researcher, Dr. Julius Oben,
head of the Department of Biochemistry, University of Yaounde in
Cameroon. The six-week study produced a mean weight loss for the
Cissus quadrangularis (Cissus CQR-300) group of 10.6 pounds compared
with a gain of 2.6 pounds for the control group. The Cissus CQR-300
group also experienced a reduction in BMI (4.1 percent), fasting
blood glucose (14.6 percent), total cholesterol (18.0 percent), LDL
(bad) cholesterol (29.0 percent), triglycerides (21.6 percent), and
plasma malondialdehyde/fat metabolites (45.5 percent). The Cissus
CQR-300 group experienced an increase of 21.1 percent in HDL (good)
cholesterol, 53.3 percent in 5-hydroxytryptamine/serotonin (5-HT)
and a 23.5 percent increase in serum creatinine, an indicator of
muscle building. The placebo group experienced none of these
benefits except a slight decrease in triglycerides of 3.3 percent
and a 17.0 percent increase in 5-HT.
“These results provide solid support for the efficacy of Cissus
quadrangularis as both an aid for weight management and support for
cardiovascular health and blood sugar regulation,” stated Dr. Oben.
The study included 68 obese patients (84 percent women), aged 19
to 50 years old, and ranging in weight from 155.6 to 313 pounds;
BMIs ranged from 27.0 – 48.65 kg/m2. The test group received 300
milligrams of a standardized, patented Cissus quadrangularis plant
extract (Cissus CQR-300) in two equal doses before meals, while the
control group received a placebo. All were directed to maintain
their normal diets and level of physical activity. “We are gratified
by the results of this latest research,” stated Soy Labs President
Ryan Schmidt. “Along with our proprietary AlbumaSoy™, Cissus
(CQR-300) is a key ingredient in our CORE™ formula, the foundation
for our family of CardioTrim™ products.”
About
CardioTrim™
All CardioTrim™ products feature the proprietary CORE™ formula
which includes AlbumaSoy™, Cissus (CQR-300), chromium
polynicotinate, selenium, green tea, vitamins B6 and B12, and folic
acid. AlbumaSoy™ is a novel soy albumin extract with powerful
cardioprotective benefits. The CORE formula addresses heart health
and weight management, two of the major health and wellness concerns
for virtually everyone from their mid-30s through their senior
years. With the CORE formula as a foundation, Soy Labs has four
distinct formulas to address specific health concerns of men, women,
diabetics and those who lead a particularly active lifestyle. Each
CardioTrim™ formula retails for $49.99 and is available directly
from Soy Labs. Purchase can be made by visiting the website at
www.CardioTrim.com or calling toll-free number at 877-500-TRIM.
About Soy Labs, LLC
Soy Labs develops and markets research-based soy products that
optimize health and quality of life including CardioTrim™, the
company’s flagship product line. It is a pioneer in the research and
development of AlbumaSoy™, a proprietary soy albumin extract that is
a primary component of CardioTrim™. Soy Labs is affiliated with
1Soy™, a nonprofit soy farmer cooperative based in Missouri and is
the recipient of two grants from the U.S. Department of Agriculture.
The company actively supports both the American Heart Association
and the American Diabetes Association. For more information about
the Soy Labs family of products and its research, visit the web site
at www.soylabs.com. |
|
|
